mRNA therapy for pulmonary artery hypertension(Translate Bio)

N/A

Report date: 2025/01/26 16:19:30
NME

Base Information

Drug NamemRNA therapy for pulmonary artery hypertension(Translate Bio)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTranslate Bio Ma Inc
China Registration ClassN/A

Develop Information

Active CompaniesTranslate Bio Ma Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A